NCT02249767View on ClinicalTrials.gov

Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel

PHASE3CompletedINTERVENTIONAL
Enrollment

574

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Acne
Interventions
DRUG

Tretinoin

Treatment of acne once daily in evening

All Listed Sponsors
lead

Spear Pharmaceuticals

INDUSTRY

NCT02249767 - Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel | Biotech Hunter | Biotech Hunter